These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 38003236)
1. In Silico Exploration of the Trypanothione Reductase (TryR) of Barrera-Téllez FJ; Prieto-Martínez FD; Hernández-Campos A; Martínez-Mayorga K; Castillo-Bocanegra R Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003236 [TBL] [Abstract][Full Text] [Related]
2. Insights about resveratrol analogs against trypanothione reductase of da Silva AD; Dos Santos JA; Machado PA; Alves LA; Laque LC; de Souza VC; Coimbra ES; Capriles PVSZ J Biomol Struct Dyn; 2019 Jul; 37(11):2960-2969. PubMed ID: 30058445 [TBL] [Abstract][Full Text] [Related]
3. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs. Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416 [TBL] [Abstract][Full Text] [Related]
4. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism. Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461 [TBL] [Abstract][Full Text] [Related]
5. Dataset generated for Dissection of mechanisms of Trypanothione Reductase and Tryparedoxin Peroxidase through dynamic network analysis and simulations in leishmaniasis. Kumar A; Saha B; Singh S Data Brief; 2017 Dec; 15():757-769. PubMed ID: 29159213 [TBL] [Abstract][Full Text] [Related]
6. Involvement of tryparedoxin peroxidase (TryP) and trypanothione reductase (TryR) in antimony unresponsive of Leishmania tropica clinical isolates of Iran. Nateghi-Rostami M; Tasbihi M; Darzi F Acta Trop; 2022 Jun; 230():106392. PubMed ID: 35276060 [TBL] [Abstract][Full Text] [Related]
7. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase. Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517 [TBL] [Abstract][Full Text] [Related]
8. Molecular modeling, structural analysis and identification of ligand binding sites of trypanothione reductase from Leishmania mexicana. Mutlu O J Vector Borne Dis; 2013 Mar; 50(1):38-44. PubMed ID: 23703438 [TBL] [Abstract][Full Text] [Related]
9. In silico molecular docking studies of new potential 4-phthalazinyl-hydrazones on selected Trypanosoma cruzi and Leishmania enzyme targets. Romero AH; López SE J Mol Graph Model; 2017 Sep; 76():313-329. PubMed ID: 28763686 [TBL] [Abstract][Full Text] [Related]
10. Promising Molecular Targets Related to Polyamine Biosynthesis in Drug Discovery against Leishmaniasis. Santiago-Silva KM; Camargo PG; Bispo MLF Med Chem; 2022; 19(1):2-9. PubMed ID: 35838221 [TBL] [Abstract][Full Text] [Related]
12. Targeting Trypanothione Reductase of Leishmanial major to Fight Against Cutaneous Leishmaniasis. Dukhyil AAAB Infect Disord Drug Targets; 2019; 19(4):388-393. PubMed ID: 29732996 [TBL] [Abstract][Full Text] [Related]
13. Probing the Interactions Responsible for the Structural Stability of Trypanothione Reductase Through Computer Simulation and Biophysical Characterization. Kumar A; Nimsarkar P; Singh S Protein J; 2022 Apr; 41(2):230-244. PubMed ID: 35364760 [TBL] [Abstract][Full Text] [Related]
14. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase. Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of selected antitumor agents as subversive substrate and potential inhibitor of trypanothione reductase: an alternative approach for chemotherapy of Leishmaniasis. Shukla AK; Patra S; Dubey VK Mol Cell Biochem; 2011 Jun; 352(1-2):261-70. PubMed ID: 21359528 [TBL] [Abstract][Full Text] [Related]
16. Toward a Drug Against All Kinetoplastids: From LeishBox to Specific and Potent Trypanothione Reductase Inhibitors. Ilari A; Genovese I; Fiorillo F; Battista T; De Ionna I; Fiorillo A; Colotti G Mol Pharm; 2018 Aug; 15(8):3069-3078. PubMed ID: 29897765 [TBL] [Abstract][Full Text] [Related]
17. Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum. Venkatesan SK; Shukla AK; Dubey VK J Comput Chem; 2010 Oct; 31(13):2463-75. PubMed ID: 20340105 [TBL] [Abstract][Full Text] [Related]
18. Targeting polyamine metabolism for finding new drugs against leishmaniasis: a review. Ilari A; Fiorillo A; Baiocco P; Poser E; Angiulli G; Colotti G Mini Rev Med Chem; 2015; 15(3):243-52. PubMed ID: 25769972 [TBL] [Abstract][Full Text] [Related]
19. Antileishmanial activity and trypanothione reductase effects of terpenes from the Amazonian species Croton cajucara Benth (Euphorbiaceae). Lima GS; Castro-Pinto DB; Machado GC; Maciel MA; Echevarria A Phytomedicine; 2015 Nov; 22(12):1133-7. PubMed ID: 26547537 [TBL] [Abstract][Full Text] [Related]